2m 2m 2m 2m 2m 2m 2m
VOR BIOPHARMA (VOR)
NASDAQ
$22.84+$0.54 (+2.42%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.3BMarket Cap
- -35.92%1-Year Change
- BiotechnologyIndustry
VOR BIOPHARMA (VOR)
$22.84+$0.54 (+2.42%)
VOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.30 | ||
Change | -$0.04 (-0.18%) | ||
Open | $22.83 | ||
High | $23.47 | ||
Low | $22.20 | ||
Previous Close | $22.34 | ||
Volume | 800,379 | ||
30-Day Average Volume | 733,945 | ||
1-Week Change | -10.98% | ||
1-Month Change | -5.47% | ||
1-Year Change | -35.92% | ||
3-Year Change | -55.04% | ||
5-Year Change | -92.79% | ||
Fundamentals | |||
Shares Outstanding | 59.2M | ||
Total Assets | $481.1M | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$62.8M | ||
Free Cash Flow | -$25.5M | ||
EBIT | -$62.8M | ||
EBITDA | -$62.8M | ||
Net Working Capital | $450.3M | ||
EPS | -$1.16 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -7 | ||
P/E | -19 | ||
PEG | -0 | ||
Price/Free Cash Flow | -52 | ||
Price/Operating Cash Flow | -52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue